Patrick D. Kirwin

CIK: 0001927062

Transaction Breakdown

Open Market Buys (P)1 (25.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

PMN

ProMIS Neurosciences Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

PMN
ProMIS Neurosciences Inc.
Apr 22, 2026
Purchase(P)
Indirect
4K shares at avg. $11.33$45K
PMN
ProMIS Neurosciences Inc.
Feb 3, 2026
Award(A)
Direct
3.1K shares at avg. $12.13$37K
PMN
ProMIS Neurosciences Inc.
Jun 12, 2025
Award(A)
Option (right to buy)
Direct
20K shares-
PMN
ProMIS Neurosciences Inc.
Oct 3, 2024
Award(A)
Option (right to buy)
Direct
40K shares-

		Type	Shares	Price		Ownership
Apr 22, 2026	PMN ProMIS Neurosciences Inc.	Purchase(P)	4,000	$11.33	$45,320	Indirect
Feb 3, 2026	PMN ProMIS Neurosciences Inc.	Award(A)	3,050	$12.13	$36,997	Direct
Jun 12, 2025	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	20,000	-	-	Direct
Oct 3, 2024	PMN ProMIS Neurosciences Inc.	Award(A) Option (right to buy)	40,000	-	-	Direct

1-4 of 4 transactions

About Kirwin Patrick D.

Kirwin Patrick D. (SEC CIK 0001927062) files insider reports with the SEC as Director of ProMIS Neurosciences Inc. (PMN).

Signal8 holds 4 ownership filings by Kirwin Patrick D., all Form 4s, filed between Oct 7, 2024 and Apr 23, 2026. Those filings report 4 transactions, from Oct 3, 2024 to Apr 22, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Kirwin Patrick D.'s filings is in TORONTO.

Recent filings by Kirwin Patrick D.

Apr 22, 2026: Open-market purchase of PMN shares (Form 4, code P).
Feb 3, 2026: Grant or award of PMN shares (Form 4, code A).
Jun 12, 2025: Grant or award of PMN derivative securities (Form 4, code A).
Oct 3, 2024: Grant or award of PMN derivative securities (Form 4, code A).

Other insiders filing for ProMIS Neurosciences Inc. (PMN)

Williams Eugene, Director
Cashman Neil, Chief Scientific Officer
Rubino Ivana, Chief Commercial Officer
Kaplan Johanne, Chief Development Officer
WYMAN WILLIAM W, Director
Warma Neil K, Chief Executive Officer

How to read Form 4 transaction codes